|Bid||82.49 x 300|
|Ask||82.50 x 100|
|Day's Range||81.46 - 82.58|
|52 Week Range||64.18 - 86.72|
|PE Ratio (TTM)||39.93|
|Dividend & Yield||2.08 (2.53%)|
|1y Target Est||N/A|
However, if you were running an R&D organization, would you use your precious resources to invest in diabetes R&D, or would you look at other important areas like cancer and rare diseases, where the need is great but the ultimate development costs are less?
Q2 2017 Eli Lilly and Co Earnings Call
Yesterday, shares fop Eli Lilly (LLY) dropped 3% after the pharmaceutical giant beat earnings forecasts but said that a new drug application for a rheumatoid arthritis treatment had been delayed. Leerink ...